FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)
Clinical trial NCT04442984 · UNKNOWN
Trial details
- NCT number
- NCT04442984
- Sponsor
- Blokhin's Russian Cancer Research Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-03
- Primary completion
- 2021-11-03
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.